Latest Dashboards
See below for our range of available dashboards.
Rare Diseases Medicines
In Europe, a rare disease is defined as a life-threatening or chronic disease or condition affecting fewer than 5 in 10,000 people – which means that there are approximately 3.5 million people in the UK and 30 million people across Europe suffering from a rare disease. There are between 6,000 and 8,000 known rare diseases, and only about 5% of these have an approved treatment option. This dashboard provides an overview of emerging rare disease medicinal products currently monitored by the NIHR Innovation Observatory on our internal database, Medicines Innovation Database (MInD). It provides the user with the details of the clinical trials targeting the prevention and/or treatment of rare diseases.
Obesity Medicines
This dashboard provides an overview of emerging obesity medicines that have been identified by the NIHR Innovation Observatory. It provides the user with the details of the medicinal products targeting the prevention and/or treatment of obesity primarily, or as a co-morbidity, including their mode of action, therapeutic class, and clinical trial details.
AI-Based Healthcare Technologies
Artificial Intelligence,- Machine Learning- and Deep Learning- enabled medical technologies encompass a diverse range of technologies. They offer exciting new possibilities in the diagnosis, management and treatment of diseases and injuries. This dashboard provides an overview of trends in innovation of AI-based medical technologies, identified through clinical trial registries. Additionally, this dashboard also provides analysis of trends of AI-based medical technologies approval by FDA from 1995-2023, extracted from FDA database. For further details about implications and insights from our results, please refer to our report.
Advanced Therapy Medicinal Products monitored by the NIHR Innovation Observatory
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer ground-breaking new opportunities for the treatment of disease and injury. This dashboard provides an overview of ATMP medicines that have been monitored by the NIHR IO on our internal database, MInD, since April 2017. It provides the user with the details of the ATMP products including the therapy areas, development stage, EMA designations and information on the type of innovations (eg monotherapy vs combination, cancer and rare indications).
Biosimilar medicines monitored by the NIHR Innovation Observatory
This dashboard provides an overview of biosimilar medicines that have been monitored by the NIHR Innovation Observatory on our internal database, MInD, since April 2017.
Repurposed medicines
This dashboard provides the user with an overview of repurposed medicines that have been identified by the NIHR Innovation Observatory from clinical trial registries and our internal database MInD.
Covid-19 Therapeutics
This dashboard provides the user with data on interventions (medicinal products including vaccines) in clinical trials for treatment and/or prevention of COVID-19 search period 2019-March 2023
Covid-19 Diagnostics
Between March 2020-February 2023, the NIHR Innovation Observatory’s Medical Devices team applied advanced horizon scanning methodologies and tools to compile a diagnostic landscape of all SARS-CoV-2 tests (commercialised/ in development) for the diagnosis of COVID-19.
